Napolitano Richard J's Form 4 filing
Teladoc Health, Inc. (TDOC) · filed Mar 5, 2024
- Accession no.
- 0001477449-24-000048
- Filed
- Mar 5, 2024
- Trade date
- Mar 1-4, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 8 non-derivative transactions and 9 derivative transactions. Open-market sales total $54.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Napolitano Richard JCIK 0001599417 | Officer (CHIEF ACCOUNTING OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +1,604 | –F1 | – | 13,353 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +504 | –F1 | – | 13,857 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +1,481 | –F2 | – | 15,338 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +337 | –F2 | – | 15,675 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +565 | –F2 | – | 16,240 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +894 | –F2 | – | 17,134 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseAcquired | +4,708 | –F2 | – | 21,842 | Direct | |
| Mar 4, 2024 | Common Stock | SSaleDisposed | −3,765 | $14.52 | −$54,667.8 | 18,077 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +4,814 | $0.00 | $0 | 4,814 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −1,604 | $0.00 | $0 | 3,210 | Direct | |
| Mar 1, 2024 | Common Stock | AGrant or awardAcquired | +1,515 | $0.00 | $0 | 1,515 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −504 | $0.00 | $0 | 1,011 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −1,481 | $0.00 | $0 | 2,963 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −337 | $0.00 | $0 | 1,348 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −565 | $0.00 | $0 | 2,260 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −894 | $0.00 | $0 | 4,472 | Direct | |
| Mar 1, 2024 | Common Stock | MOption exerciseDisposed | −4,708 | $0.00 | $0 | 9,418 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 2 transactions in Table I.
- F2
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Referenced by the price of 5 transactions in Table I.